Reduced Cardiac 123i-Metaiodobenzylguanidine Uptake In Patients With Spinocerebellar Ataxia Type 2: A Comparative Study With Parkinson'S Disease(507 views) De Rosa A, Pappata S, Pellegrino T, De Leva MF, Maddaluno G, Fiumara G, Carotenuto R, Petretta M, Filla A, De Michele G, Cuocolo A
Keywords: 123i-Metaiodobenzylguanidine, Cardiac Sympathetic Function, Spinocerebellar Ataxia Type 2, (3 Iodobenzyl) Guanidine I 123, Diagnostic Agent, Adult, Article, Autonomic Dysfunction, Clinical Article, Comparative Study, Controlled Study, Diagnostic Accuracy, Drug Uptake, Female, Heart Function, Heart Scintiscanning, Heart To Mediastinum Ratio, Human, Myocardial Washout Rate, Parkinson Disease, Radiological Parameters, Scoring System, Spinocerebellar Degeneration, Adrenergic System, Heart Muscle, Innervation, Metabolism, Middle Aged, Pathophysiology, Transport At The Cellular Level, Young Adult, 3-Iodobenzylguanidine, Biological Transport, Sympathetic Nervous System, 3-Iodobenzylguanidine Diagnostic Use Metabolism, Heart Innervation Radionuclide Imaging, Myocardium Metabolism, Parkinson Disease Metabolism Radionuclide Imaging, Spinocerebellar Ataxias Metabolism Radionuclide Imaging, Sympathetic Nervous System Physiopathology Radionuclide Imaging, (3 Iodobenzyl)guanidine I 123,
Affiliations: *** IBB - CNR ***
Department of Neurosciences and Reproductive and Odontostomatologic Sciences, University Federico II, Naples, Italy.
Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy
Department of Translational Medical Sciences, University Federico II, Naples, Italy
SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy
Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy
References: Taki, J., Yoshita, M., Yamada, M., Tonami, N., Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: It can be a specific marker for Lewy body disease (2004) Ann Nucl Med, 18, pp. 453-461. , 15515743 10.1007/BF0298456
Damier, P., Hirsch, E.C., Agid, Y., Graybiel, A.M., The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease (1999) Brain, 122, pp. 1437-1448. , 10430830 10.1093/brain/122.8.1437
Wakabayashi, K., Tanji, K., Mori, F., Takahashi, H., The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of alpha-synuclein aggregates (2007) Neuropathology, 27, pp. 494-506. , 18018486 10.1111/j.1440-1789.2007.00803.x
Wolters, E.C., Non-motor extranigral signs and symptoms in Parkinson's disease (2009) Parkinsonism Relat Disord, 15, pp. 6-S12. , 20083010 10.1016/S1353-8020(09)70770-9
Oka, H., Toyoda, C., Yogo, M., Mochio, S., Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease (2011) J Neural Transm, 118, pp. 1323-1327. , 21331459 10.1007/s00702-011-0598-5
Treglia, G., Cason, E., Stefanelli, A., Cocciolillo, F., Di Giuda, D., Fagioli, G., MIBG scintigraphy in differential diagnosis of Parkinsonism: A meta-analysis (2012) Clin Auton Res, 22, pp. 43-55. , 21792729 10.1007/s10286-011-0135-5
Magaña, J.J., Velázquez-Pérez, L., Cisneros, B., Spinocerebellar ataxia type 2: Clinical presentation, molecular mechanisms, and therapeutic perspectives (2013) Mol Neurobiol, 47, pp. 90-104. , 22996397 10.1007/s12035-012-8348-8
Durr, A., Autosomal dominant cerebellar ataxias: Polyglutamine expansions and beyond (2010) Lancet Neurol, 9, pp. 885-894. , 20723845 10.1016/S1474-4422(10)70183-6 1:CAS:528:DC%2BC3cXhtVersbbK
De Joanna, G., De Rosa, A., Salvatore, E., Castaldo, I., De Luca, N., Izzo, R., Autonomic nervous system abnormalities in spinocerebellar ataxia (2008) J Neurol Sci, 275, pp. 60-63. , 18755482 10.1016/j.jns.2008.07.015
Yomono, H.S., Kurisaki, H., Hebisawa, A., Sakiyama, Y., Saito, Y., Murayama, S., Autopsy case of SCA2 with Parkinsonian phenotype (2010) Rinsho Shinkeigaku, 50, pp. 156-162. , 20235484 10.5692/clinicalneurol.50.156
Rascol, O., Schelosky, L., 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders (2009) Mov Disord, 24, pp. 732-S741. , 19877202 10.1002/mds.22499
Schmitz-Hübsch, T., Du Montcel, S.T., Baliko, L., Berciano, J., Boesch, S., Depondt, C., Scale for the assessment and rating of ataxia: Development of a new clinical scale (2006) Neurology, 66, pp. 1717-1720. , 16769946 10.1212/01.wnl.0000219042.60538.92
Fahn, S., Elton, R.L., The Unified Parkinson's disease rating scale (1987) Recent Developments in Parkinson's Disease, Vol. 2, pp. 153-163. , Members of the UPDRS Development Committee S. Fahn C.D. Marsden D.B. Calne M. Goldstein (eds) Macmillan Healthcare Information Florham Park 293-304
Hoehn, M.M., Yahr, M.D., Parkinsonism: Onset, progression and mortality (1967) Neurology, 17, pp. 427-442. , 6067254 10.1212/WNL.17.5.427 1:STN:280:DyaF2s7jvFSgsg%3D%3D
Flotats, A., Carrió, I., Agostini, D., Le Guludec, D., Marcassa, C., Schäfers, M., Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1802-1812. , EANM Cardiovascular Committee European Council of Nuclear Cardiology et al. 20577740 10.1007/s00259-010-1491-4
Dürr, A., Smadja, D., Cancel, G., Lezin, A., Stevanin, G., Mikol, J., Autosomal dominant cerebellar ataxia type i in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families (1995) Brain, 118, pp. 157-181. , 10.1093/brain/118.6.1573
Gierga, K., Bürk, K., Bauer, M., Orozco Diaz, G., Auburger, G., Schultz, C., Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2) (2005) Acta Neuropathol, 109, pp. 617-631. , 15906049 10.1007/s00401-005-1014-8 1:STN:280:DC%2BD2MzjtFehtw%3D%3D
Kazuta, T., Hayashi, M., Shimizu, T., Iwasaki, A., Nakamura, S., Hirai, S., Autonomic dysfunction in Machado-Joseph disease assessed by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy (2000) Clin Auton Res, 10, pp. 111-115. , 10954068 10.1007/BF02278014 1:STN:280:DC%2BD3M%2FltVerug%3D%3D
Pellegrino, T., Petretta, M., De Luca, S., Paolillo, S., Boemio, A., Carotenuto, R., Observer reproducibility of results from a low-dose (123)I- metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure (2013) Eur J Nucl Med Mol Imaging, , doi: 10.1007/s00259-013-2461-4
Kline, R.C., Swanson, D.P., Wieland, D.M., Thrall, J.H., Gross, M.D., Pitt, B., Myocardial imaging in man with I-123 meta-iodobenzylguanidine (1981) J Nucl Med, 22, pp. 129-132. , 7463156 1:CAS:528:DyaL3MXhtFKru78%3D
Sisson, J.C., Shapiro, B., Meyers, L., Mallette, S., Mangner, T.J., Wieland, D.M., Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man (1987) J Nucl Med, 28, pp. 1625-1636. , 3655915 1:CAS:528:DyaL1MXmvFCrtA%3D%3D
Estorch, M., Carrió, I., Berná, L., López-Pousa, J., Torres, G., Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age (1995) J Nucl Cardiol, 2, pp. 126-132. , 9420777 1:STN:280:DyaK1c%2Fot1entQ%3D%3D
Ji, S.Y., Travin, M.I., Radionuclide imaging of cardiac autonomic innervation (2010) J Nucl Cardiol, 17, pp. 655-666. , 20454877 10.1007/s12350-010-9239-x
Netravathi, M., Sathyaprabha, T.N., Jayalaxmi, K., Datta, P., Nirmala, M., Pal, P.K., A comparative study of cardiac dysautonomia in autosomal dominant spinocerebellar ataxias and idiopathic sporadic ataxias (2009) Acta Neurol Scand, 120, pp. 204-209. , 19178387 10.1111/j.1600-0404.2008.01144.x 1:STN:280: DC%2BD1MrptVOqtQ%3D%3D
Takao, M., Aoyama, M., Ishikawa, K., Sakiyama, Y., Yomono, H., Saito, Y., Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology (2011) BMJ Case Rep, 2011, p. 0120113685. , 22700602 10.1136/bcr.01.2011.3685
Varrone, A., Salvatore, E., De Michele, G., Barone, P., Sansone, V., Pellecchia, M.T., Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism (2004) Ann Neurol, 553, pp. 426-430. , 10.1002/ana.20054
Estrada, R., Galarraga, J., Orozco, G., Nodarse, A., Auburger, G., Spinocerebellar ataxia 2 (SCA2): Morphometric analyses in 11 autopsies (1999) Acta Neuropathol, 97, pp. 306-310. , 10090679 10.1007/s004010050989 1:STN:280:DyaK1M7ovFSrug%3D%3D
Filla, A., De Michele, G., Banfi, S., Santoro, L., Perretti, A., Cavalcanti, F., Has spinocerebellar ataxia type 2 a distinct phenotype? Genetic and clinical study of an Italian family (1995) Neurology, 45, pp. 793-796. , 7723972 10.1212/WNL.45.4.793 1:STN:280:DyaK2M3ktVyltQ%3D%3D
Van De Warrenburg, B.P., Notermans, N.C., Schelhaas, H.J., Van Alfen, N., Sinke, R.J., Knoers, N.V., Peripheral nerve involvement in spinocerebellar ataxias (2004) Arch Neurol, 61, pp. 257-261. , 14967775 10.1001/archneur.61.2.257
Perretti, A., Santoro, L., Lanzillo, B., Filla, A., De Michele, G., Barbieri, F., Autosomal dominant cerebellar ataxia type I: Multimodal electrophysiological study and comparison between SCA1 and SCA2 patients (1996) J Neurol Sci, 142, pp. 45-53. , 8902719 10.1016/0022-510X(96)00140-2 1:STN:280:DyaK2s%2FlvVequw%3D%3D
Reduced Cardiac 123i-Metaiodobenzylguanidine Uptake In Patients With Spinocerebellar Ataxia Type 2: A Comparative Study With Parkinson'S Disease